tiprankstipranks
Advertisement
Advertisement

LPCN Stock Latest News

Lipocine Shareholders Approve Directors, Auditor and Incentive Plan
Company AnnouncementsLipocine Shareholders Approve Directors, Auditor and Incentive Plan
1d ago
8K
LPCN
Lipocine Plans KOL Webinar on Oral PPD Candidate
PremiumCompany Announcements
Lipocine Plans KOL Webinar on Oral PPD Candidate
2d ago
8K
LPCN
Lipocine Showcases Phase 3 Data in Postpartum Depression
PremiumCompany Announcements
Lipocine Showcases Phase 3 Data in Postpartum Depression
10d ago
8K
LPCN
Lipocine Showcases Phase 3 Data for Postpartum Depression
PremiumCompany Announcements
Lipocine Showcases Phase 3 Data for Postpartum Depression
18d ago
8K
LPCN
Lipocine Showcases Pipeline at Virtual Healthcare Conference
PremiumCompany Announcements
Lipocine Showcases Pipeline at Virtual Healthcare Conference
19d ago
8K
LPCN
Lipocine Updates Corporate Presentation for Investor Communications
PremiumCompany AnnouncementsLipocine Updates Corporate Presentation for Investor Communications
29d ago
8K
LPCN
LPCN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
LPCN Earnings this Week: How Will it Perform?
1M ago
LPCN
Lipocine Reshapes Board Leadership Amid Strategic Shift
Premium
Company Announcements
Lipocine Reshapes Board Leadership Amid Strategic Shift
2M ago
8K
LPCN
Lipocine price target lowered to $6 from $11 at Alliance Global
PremiumThe Fly
Lipocine price target lowered to $6 from $11 at Alliance Global
2M ago
LPCN
Lipocine downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Lipocine downgraded to Neutral from Buy at H.C. Wainwright
2M ago
LPCN
Lipocine weighs path after LPCN 1154 Phase 3 miss
PremiumCompany Announcements
Lipocine weighs path after LPCN 1154 Phase 3 miss
2M ago
8K
LPCN
Lipocine Updates Investor Presentation to Refine Market Messaging
PremiumCompany Announcements
Lipocine Updates Investor Presentation to Refine Market Messaging
2M ago
8K
LPCN
Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial
PremiumThe FlyLipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial
2M ago
LPCN
Lipocine price target raised to $11 from $6.75 at Alliance Global
Premium
The Fly
Lipocine price target raised to $11 from $6.75 at Alliance Global
3M ago
LPCN
Lipocine Files Prospectus to Enable $50M Stock Offering
Premium
Company Announcements
Lipocine Files Prospectus to Enable $50M Stock Offering
3M ago
8K
LPCN
LPCN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LPCN Upcoming Earnings Report: What to Expect?
3M ago
LPCN
Lipocine Completes Phase 3 Trial for Postpartum Depression
PremiumCompany Announcements
Lipocine Completes Phase 3 Trial for Postpartum Depression
4M ago
8K
LPCN
Lipocine Updates Investor Presentation to Reflect Latest Strategy
PremiumCompany Announcements
Lipocine Updates Investor Presentation to Reflect Latest Strategy
4M ago
8K
LPCN
Lipocine announces last patient visit in Phase 3 trial of LPCN 1154
PremiumThe Fly
Lipocine announces last patient visit in Phase 3 trial of LPCN 1154
4M ago
LPCN
Lipocine price target raised to $15 from $7 at H.C. Wainwright
PremiumThe FlyLipocine price target raised to $15 from $7 at H.C. Wainwright
5M ago
LPCN
Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug
Premium
Company Announcements
Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug
5M ago
8K
LPCN
Lipocine completes enrollment, dosing in Phase 3 trial of LPCN 1154
Premium
The Fly
Lipocine completes enrollment, dosing in Phase 3 trial of LPCN 1154
5M ago
LPCN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >